Medical Indications for Dimenhydrinate

Primary Indications

• Dimenhydrinate is an H1-receptor antagonist that serves as a first-line pharmacologic antiemetic therapy for nausea and vomiting 1
• Dimenhydrinate at doses of 25-50 mg three times daily is recommended for treating nausea and vomiting in refractory gastroparesis 2

Use in Pregnancy

• Dimenhydrinate is considered safe as a first-line pharmacologic antiemetic therapy for persistent nausea and vomiting during pregnancy (NVP) when non-pharmacologic approaches are ineffective 1
• The American College of Obstetricians and Gynecologists (ACOG) recommends dimenhydrinate among other H1-receptor antagonists for persistent NVP 1

Use in Vestibular Disorders

• Dimenhydrinate is used in the treatment of Ménière's disease to manage vertigo symptoms 3

Pediatric Use

• For children with acute gastroenteritis, antiemetics including dimenhydrinate may be considered, but are not a substitute for fluid and electrolyte therapy 4
• Dimenhydrinate should not be given to children under 18 years with acute diarrhea 4

Dosing Considerations

• Adults: Typical dosing is 25-50 mg three times daily 2

Dimenhydrinate: Pharmacologic Effects and Recommended Dosing

Anticholinergic Adverse Effects

• Dimenhydrinate’s anticholinergic properties contribute to its antiemetic action but also cause side effects such as dry mouth, urinary retention, blurred vision, and epigastric discomfort. 5

Sedative Effects

• The drug induces sedation through central nervous system depression, with an onset of several minutes when given intravenously and a duration of effect lasting approximately 4–6 hours. 5

Standard Adult Dosing

• The typical adult regimen is 25–50 mg administered three times daily by oral, intramuscular, or intravenous route, with a maximum of six doses within a 24‑hour period. 5